All medicines centrally authorised in the EU (EMA)
linaclotide
linagliptin
risankizumab
nintedanib
tezepelumab
tolebrutinib
Ipilimumab
N07XX
L01F
human normal immunoglobulin (IVIg)
propranolol hydrochloride
denosumab
nivolumab
Erdafitinib
elinzanetant
tofersen
osimertinib mesilate
ciclosporin
Pomalidomide
cannabidiol
Page 15 of 134 • 20 of 2,678 Medicines